IP Library Assignment 027423/0058
Patent Assignment
Reel/Frame 027423/0058

Security Agreement

Recorded: 2011-12-20 Pages: 10
Assignor
CELATOR PHARMACEUTICALS, INC.
Executed: 2011-12-15
Assignees
BDC CAPITAL INC.
SUITE 200, 505 BURRARD STREET, P.O. BOX 6, VANCOUVER, BRITISH COLUMBIA, V7X 1M3, CANADA
DOMAIN PARTNERS VI, L.P.
ONE PALMER SQUARE, C/O DOMAIN ASSOCIATES, L.L.C., PRINCETON, NEW JERSEY, 08542
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
2929 ARCH STREET - CIRA CENTRE, PHILADELPHIA, PENNSYLVANIA, 19104-2868
QUAKER BIOVENTURES, L.P.
2929 ARCH STREET - CIRA CENTRE, PHILADELPHIA, PENNSYLVANIA, 19104-2868
THOMAS, MCNERNEY & PARTNERS II, L.P.
263 TRESSER BOULEVARD, ONE STAMFORD PLAZA - SUITE 1600, STAMFORD, CONNECTICUT, 06901
TMP ASSOCIATES II, L.P.
263 TRESSER BOULEVARD, ONE STAMFORD PLAZA - SUITE 1600, STAMFORD, CONNECTICUT, 06901
TMP NOMINEE II, LLC
263 TRESSER BOULEVARD, ONE STAMFORD PLAZA - SUITE 1600, STAMFORD, CONNECTICUT, 06901
VENTURES WEST 7 LIMITED PARTNERSHIP
SUITE 400, 999 WEST HASTINGS STREET, VANCOUVER, BRITISH COLUMBIA, V6C 2W2, CANADA
VENTURES WEST 7 U.S. LIMITED PARTNERSHIP
SUITE 400, 999 WEST HASTINGS STREET, VANCOUVER, BRITISH COLUMBIA, V6C 2W2, CANADA
WORKING OPPORTUNITY FUND (EVCC) LTD.
2600-1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 3R5, CANADA
Covered Properties (19)
Liposome Loading with Metal Ions
Patent: 7,238,367 →
Application: 10/264,818 →
Publication: US 2003/0091621
Lipid Carrier Compositions with Enhanced Blood Stability
Patent: 8,518,437 →
Application: 10/294,474 →
Publication: US 2003/0124181
Compositions for Delivery of Drug Combinations
Patent: 7,850,990 →
Application: 10/417,631 →
Publication: US 2004/0022817
Compositions for Delivery of Drug Combinations
Patent: 9,271,931 →
Application: 10/553,373 →
Publication: US 2007/0298092
Compositions for delivery of drug combinations
Application: 11/304,328 →
Publication: US 2006/0165771
Fixed Ratio Drug Combination Treatments for Solid Tumors
Patent: 7,842,676 →
Application: 11/586,215 →
Publication: US 2009/0023680
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Patent: 8,022,279 →
Application: 11/587,112 →
Publication: US 2007/0286897
Particulate Constructs For Release of Active Agents
Application: 11/632,884 →
Publication: US 2008/0299205
Compositions for delivery of drug combinations
Application: 11/701,326 →
Publication: US 2007/0148255
Compositions for Delivery of Drug Combinations
Application: 11/841,786 →
Publication: US 2008/0075762
Liposome Loading with Metal Ions
Patent: 7,744,921 →
Application: 11/842,130 →
Publication: US 2008/0044464
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Patent: 8,092,828 →
Application: 12/032,583 →
Publication: US 2008/0199515
Localized Delivery of Drug Combinations
Application: 12/095,494 →
Publication: US 2009/0304766
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Application: 12/526,930 →
Publication: US 2010/0303895
Fixed Ratio Camptothecens/Platinum Agents
Application: 12/673,157 →
Publication: US 2012/0003294
Taxane Delivery System
Patent: 8,486,924 →
Application: 12/741,954 →
Publication: US 2010/0331290
Lipid Carrier Compositions with Enhanced Blood Stability
Application: 12/884,098 →
Publication: US 2011/0002982
Combination Methods and Compositions
Application: 13/122,454 →
Publication: US 2011/0223241
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Patent: 8,431,806 →
Application: 13/237,807 →
Publication: US 2012/0009252
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 28, 2011
From: TARDI, PAUL; WEBB, MURRAY; MAYER, LAWRENCE D.; ICKENSTEIN, LUDGER M.
To: CELATOR TECHNOLOGIES, INC.
Reel/Frame 026196/0318 →
Change of Name Apr 28, 2011
From: CELATOR PHARMACEUTICALS CORP. (FORMERLY CELATOR TECHNOLOGIES, INC.)
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 026196/0321 →
Assignment of Assignor's Interest May 10, 2011
From: TARDI, PAUL; MAYER, LAWRENCE; BERMUDES, DAVID
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 026255/0571 →
Assignment of Assignor's Interest Jul 18, 2011
From: TARDI, PAUL; JOHNSTONE, SHARON; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 026609/0441 →
Assignment of Assignor's Interest Nov 16, 2011
From: MAYER, LAWRENCE; JOHNSTONE, SHARON; HARASYM, TROY
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 027235/0418 →
Release of Security Interest Jun 15, 2012
From: THOMAS, MCNERNEY & PARTNERS II, L.P.; TMP NOMINEE II, LLC; TMP ASSOCIATES II, L.P.; DOMAIN PARTNERS VI, L.P.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 028385/0371 →
Security Agreement Jul 12, 2016
From: CELATOR PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 039312/0397 →
Release of Security Interest May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Security Agreement May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Change of Name Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
Corrective Assignment to Correct the Removal of 8 Property Numbers Previously Recorded at Reel: 072341 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name. Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
Corrective Assignment to Correct the Remove 2 Application Numbers Previously Recorded at Reel: 07234 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name. Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →